Mckesson CORP (MCK) — SEC Filings

Overview

Mckesson CORP (MCK) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 8-K filed on Apr 6, 2026: On April 1, 2026, McKesson Corporation entered into a material definitive agreement, specifically an executed credit agreement. This agreement likely involves the creation of a direct financial obligation or an obligation under an off-balance sheet arrangement for the registrant. The filing also inc

Sentiment Summary

Across 32 filings, the sentiment breakdown is: 2 bullish, 29 neutral, 1 mixed. The dominant filing sentiment for Mckesson CORP is neutral.

Filing Type Overview

Mckesson CORP (MCK) has filed 17 8-K, 6 10-Q, 2 DEFA14A, 2 DEF 14A, 2 10-K, 1 8-K/A, 2 SC 13G/A with the SEC between Jan 2024 to Apr 2026.

Filings by Year

2026 · 2025 · 2024

Recent Filings (32)

• McKesson Corp Enters Material Definitive Agreement — 8-K · Apr 6, 2026 Risk: medium
  On April 1, 2026, McKesson Corporation entered into a material definitive agreement, specifically an executed credit agreement. This agreement likely involves t
• McKesson's Q2 Profit Soars 361% on Strong Revenue Growth, Strategic Acquisitions — 10-Q · Nov 6, 2025 Risk: medium
  McKesson Corporation reported robust financial performance for the three and six months ended September 30, 2025. Revenues for the three months increased by 10.
• 8-K Filing — 8-K · Nov 5, 2025
• McKesson Corp Files 8-K on Debt Instruments — 8-K · Sep 23, 2025 Risk: low
  McKesson Corporation filed an 8-K on September 23, 2025, reporting on Regulation FD disclosures and financial statements. The filing includes details about vari
• McKesson Corp Files 8-K on Financials & Operations — 8-K · Sep 18, 2025 Risk: low
  McKesson Corporation filed an 8-K on September 18, 2025, reporting on its results of operations and financial condition, along with other events and financial s
• McKesson Q1 Soars on Distribution Strength, Strategic Investments — 10-Q · Aug 6, 2025 Risk: medium
  McKesson Corp (MCK) reported a robust first quarter for fiscal year 2026, ending June 30, 2025. The company's revenue increased significantly, driven by strong
• McKesson Corp Files 8-K on Shareholder Votes & Debt — 8-K · Aug 1, 2025 Risk: low
  McKesson Corporation filed an 8-K on August 1, 2025, reporting on matters submitted to a vote of security holders as of July 30, 2025. The filing details variou
• McKesson Corp Files Definitive Proxy Statement — DEFA14A · Jul 2, 2025 Risk: low
  McKesson Corporation filed a Definitive Proxy Statement (DEFA14A) on July 2, 2025. This filing is related to their annual meeting and likely concerns executive
• McKesson's Executive Pay Tied to Long-Term Equity Incentives — DEF 14A · Jun 20, 2025 Risk: low
  McKesson Corp's DEF 14A filing for the fiscal year ended March 31, 2025, highlights executive compensation and governance matters. While specific revenue and ne
• McKesson Corp 8-K Filing: Debt Maturities and Common Stock — 8-K · Jun 9, 2025 Risk: low
  On June 9, 2025, McKesson Corporation filed an 8-K report detailing its financial activities. The filing includes information about its common stock and various
• McKesson Corp Issues New Debt Instruments — 8-K · May 30, 2025 Risk: low
  On May 20, 2025, McKesson Corporation (MCK) filed an 8-K report detailing the creation of a direct financial obligation. The filing specifically mentions "A1.50
• McKesson Corp Files 2025 10-K — 10-K · May 9, 2025 Risk: medium
  McKesson Corporation filed its 2025 10-K report, detailing its fiscal year ending March 31, 2025. The company, headquartered in Irving, Texas, operates in the w
• McKesson Corp Files 8-K on Operations & Financials — 8-K · May 8, 2025 Risk: low
  McKesson Corporation filed an 8-K on May 8, 2025, reporting on its results of operations and financial condition. The filing includes financial statements and e
• McKesson Corp Files Q3 2024 10-Q — 10-Q · Feb 6, 2025 Risk: low
  McKesson Corporation filed its 10-Q for the period ending December 31, 2024. The filing covers the third quarter of their fiscal year. Key financial data and op
• McKesson Corp Files 8-K/A Amendment — 8-K/A · Feb 5, 2025 Risk: low
  McKesson Corporation filed an 8-K/A on February 5, 2025, to amend its previous filing. This amendment pertains to the company's financial statements and exhibit
• McKesson Corp Files Q2 2024 10-Q — 10-Q · Nov 7, 2024 Risk: low
  McKesson Corporation filed its 10-Q for the period ending September 30, 2024. The company reported financial results for the second quarter and the first half o
• McKesson Corp Files 8-K on Financials and Debt — 8-K · Nov 6, 2024 Risk: low
  McKesson Corporation filed an 8-K on November 6, 2024, reporting on its results of operations and financial condition, and including financial statements and ex
• McKesson Prices $6.25B in Senior Notes — 8-K · Sep 10, 2024 Risk: medium
  On September 5, 2024, McKesson Corporation (MCK) announced the pricing of its senior unsecured notes. The company priced $1.500 billion of notes due 2025, $1.62
• McKesson Corp Files 8-K for Regulation FD Disclosure — 8-K · Sep 5, 2024 Risk: low
  McKesson Corporation filed an 8-K on September 5, 2024, to report a Regulation FD Disclosure. The filing does not contain specific financial figures or new mate
• McKesson Prices $6.25B Senior Notes Offering — 8-K · Aug 26, 2024 Risk: low
  McKesson Corporation announced on August 26, 2024, that it has priced a public offering of $1.500 billion aggregate principal amount of 1.500% senior notes due
• McKesson Corp Q1 2025 10-Q Filed — 10-Q · Aug 7, 2024 Risk: low
  McKesson Corporation filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the first fiscal q
• McKesson Corp Files 8-K on Security Holder Votes — 8-K · Aug 2, 2024 Risk: low
  McKesson Corporation filed an 8-K on July 31, 2024, reporting on the submission of matters to a vote of security holders. The filing details various financial i
• McKesson Corp Files Definitive Proxy Statement — DEFA14A · Jul 8, 2024 Risk: low
  McKesson Corporation filed a Definitive Proxy Statement (DEFA14A) on July 8, 2024. This filing is related to the company's annual meeting and likely concerns th
• DEF 14A Filing — DEF 14A · Jun 21, 2024
• McKesson Appoints New Chief Accounting Officer — 8-K · Jun 3, 2024 Risk: low
  McKesson Corporation announced on May 28, 2024, the appointment of Michelle L. Duca as Senior Vice President and Chief Accounting Officer, effective June 3, 202
• McKesson Corp Files 2024 10-K — 10-K · May 8, 2024 Risk: medium
  McKesson Corporation filed its 10-K for the fiscal year ending March 31, 2024, reporting on its operations in wholesale drug distribution and related services.
• McKesson Corp Files 8-K on Financials and Notes — 8-K · May 7, 2024 Risk: low
  McKesson Corporation filed an 8-K on May 7, 2024, reporting on its financial condition and results of operations. The filing includes information related to its
• Vanguard Amends McKesson Stake to 18.0% as of Dec 29, 2023 — SC 13G/A · Feb 13, 2024 Risk: low
  The Vanguard Group, a major investment management company, filed an amended SC 13G/A on February 13, 2024, disclosing its ownership in McKesson Corp. As of Dece
• McKesson Corp Files 10-Q for Period Ending December 31, 2023 — 10-Q · Feb 8, 2024 Risk: medium
  MCKESSON CORP (MCK) filed a Quarterly Report (10-Q) with the SEC on February 8, 2024. McKesson Corporation filed a 10-Q report for the period ending December 31
• MCKESSON 8-K: Financial Condition & Operations Update — 8-K · Feb 7, 2024
  McKesson Corporation filed an 8-K on February 7, 2024, to report its financial condition and results of operations. This filing specifically mentions various de
• BlackRock Amends McKesson Stake, Signals Portfolio Adjustment — SC 13G/A · Jan 25, 2024
  BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating a change in their ownership of McKesson Corporation's Common Stock as of December 31, 2
• MCKESSON REPORTS OFFICER/DIRECTOR CHANGES, COMPENSATORY ARRANGEMENTS — 8-K · Jan 9, 2024
  McKesson Corporation filed an 8-K on January 9, 2024, reporting events that occurred on January 8, 2024. The filing indicates changes related to the departure o

Risk Profile

Risk Assessment: Of MCK's 27 recent filings, 0 were flagged as high-risk, 7 as medium-risk, and 20 as low-risk. The overall risk profile suggests relatively low risk with generally favorable filings.

Financial Highlights

Key financial metrics from Mckesson CORP's most recent 10-Q filing (Nov 6, 2025):

• Revenue: $103.15B
• Net Income: $1.11B
• EPS: $8.92
• Debt-to-Equity: N/A
• Cash Position: $4.00B
• Operating Margin: 1.36%
• Total Assets: $84.16B
• Total Debt: $6.01B

Key Executives

• Michelle L. Duca

Industry Context

McKesson operates in the highly competitive pharmaceutical distribution and healthcare services industry. Key trends include increasing consolidation, the growing importance of specialty pharmaceuticals (especially oncology), and a focus on value-based care models. Companies are investing in technology and data analytics to improve supply chain efficiency and patient outcomes.

Top Tags

debt (5) · healthcare (5) · financing (4) · financial-condition (4) · 10-Q (4) · filing (3) · corporate-governance (3) · financials (3) · amendment (3) · Healthcare Distribution (2)

Executive Compensation

From the most recent DEF 14A filing (Jun 20, 2025):

• full name — exact role: $X

Key Numbers

• Revenues: $103.15B — Increased 10.1% for the three months ended September 30, 2025, compared to $93.65 billion in 2024.
• Net income attributable to McKesson Corporation: $1.11B — Increased 360.6% for the three months ended September 30, 2025, compared to $241 million in 2024.
• Diluted Earnings Per Common Share: $8.92 — Increased from $1.87 for the three months ended September 30, 2025, compared to 2024.
• Six-month Revenues: $200.98B — Increased 16.2% for the six months ended September 30, 2025, compared to $172.93 billion in 2024.
• Six-month Net income attributable to McKesson Corporation: $1.89B — Increased 63.8% for the six months ended September 30, 2025, compared to $1.16 billion in 2024.
• PRISM Vision Acquisition Cost: $871M — Cash payment for 80% controlling interest on April 1, 2025.
• Core Ventures Acquisition Cost: $2.5B — Cash payment for 70% controlling interest on June 2, 2025.
• Long-term Debt: $6.01B — Increased from $4.46 billion as of March 31, 2025, reflecting financing for acquisitions.
• Cash and Cash Equivalents: $4.00B — Decreased from $5.69 billion as of March 31, 2025, due to acquisition spending.
• Shares Outstanding: 123.4M — As of October 31, 2025, indicating share count for EPS calculation.
• Revenue: $X.XB — Increased significantly in Q1 fiscal year 2026
• Net Income: $Y.YB — Saw a healthy rise in Q1 fiscal year 2026
• Notes Due: 2025 — Maturity year for specific debt instruments.
• Fiscal Year End: 2025-03-31 — Conformed period of report for the DEF 14A filing
• Filed As Of Date: 2025-06-20 — Date the DEF 14A was officially filed with the SEC

Forward-Looking Statements

• {"claim":"Vanguard will maintain a significant, passive stake in McKesson Corp.","entity":"The Vanguard Group","targetDate":"Next 12 months","confidence":"high"}
• {"claim":"McKesson Corp will continue to maintain a stable capital structure in the next fiscal quarter.","entity":"MCKESSON CORP","targetDate":"2024-03-31","confidence":"high"}

Related Companies

CAH · ABC

Frequently Asked Questions